Proficio Capital Partners LLC Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Proficio Capital Partners LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16,156.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 917,329 shares of the exchange traded fund’s stock after buying an additional 911,686 shares during the period. Proficio Capital Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $82,615,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in XBI. Howard Capital Management Group LLC increased its stake in shares of SPDR S&P Biotech ETF by 2.6% during the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock valued at $24,514,000 after buying an additional 6,188 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its position in SPDR S&P Biotech ETF by 16.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,390 shares of the exchange traded fund’s stock valued at $2,113,000 after purchasing an additional 2,997 shares in the last quarter. Financial Advocates Investment Management bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at about $1,300,000. Petra Financial Advisors Inc. boosted its position in SPDR S&P Biotech ETF by 1.7% during the third quarter. Petra Financial Advisors Inc. now owns 9,004 shares of the exchange traded fund’s stock valued at $890,000 after purchasing an additional 152 shares in the last quarter. Finally, Focus Financial Network Inc. bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at about $218,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $87.10 on Friday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The stock’s 50-day moving average is $91.06 and its 200 day moving average is $95.80. The company has a market cap of $5.74 billion, a P/E ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.